Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 2;12(1):1810.
doi: 10.1038/s41598-022-05951-z.

Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014

Affiliations

Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014

Michael Fu et al. Sci Rep. .

Abstract

Investigate trends in myocarditis incidence and prognosis in Sweden during 2000-2014. Little data exist concerning population-trends in incidence of hospitalizations for myocarditis and subsequent prognosis. Linking Swedish National Patient and Cause of Death Registers, we identified individuals ≥ 16 years with first-time diagnosis of myocarditis during 2000-2014. Reference population, matched for age and birth year (n = 16,622) was selected from Swedish Total Population Register. Among the 8 679 cases (75% men, 64% < 50 years), incidence rate/100,000 inhabitants rose from 6.3 to 8.6 per 100,000, mostly in men and those < 50 years. Incident heart failure/dilated cardiomyopathy occurred in 6.2% within 1 year after index hospitalization and in 10.2% during 2000-2014, predominantly in those ≥ 50 years (12.1% within 1 year, 20.8% during 2000-2014). In all 8.1% died within 1 year, 0.9% (< 50 years) and 20.8% (≥ 50 years). Hazard ratios (adjusted for age, sex) for 1-year mortality comparing cases and controls were 4.00 (95% confidence interval 1.37-11.70), 4.48 (2.57-7.82), 4.57 (3.31-6.31) and 3.93 (3.39-4.57) for individuals aged < 30, 30 to < 50, 50 to < 70, and ≥ 70 years, respectively. The incidence of myocarditis during 2000-2014 increased, predominantly in men < 50 years. One-year mortality was low, but fourfold higher compared with reference population.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Incidence of myocarditis per 100,000 inhabitants in Sweden from 2000 to 2014 by sex, with or without validation in a subpopulation with a diagnosis of myocarditis validated from 2000 to 2014.
Figure 2
Figure 2
Incidence of myocarditis per 100,000 inhabitants in Sweden from 2000 to 2014 by age.
Figure 3
Figure 3
Probability of event heart failure/dilated cardiomyopathy 1 year after hospitalization from 2000 to 2014 stratified by age: < 50 and ≥ 50 years.
Figure 4
Figure 4
1-year mortality from 2000 to 2014 stratified by age: < 50 and ≥ 50 years.

References

    1. Caforio AL, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013;34(2636–2648):2648. - PubMed
    1. Pavlicek V, et al. Ventricular arrhythmias and myocardial inflammation: Long-term follow-up of patients with suspected myocarditis. Int. J. Cardiol. 2019;274:132–137. doi: 10.1016/j.ijcard.2018.07.142. - DOI - PubMed
    1. Eckart RE, et al. Sudden death in young adults: A 25-year review of autopsies in military recruits. Ann. Intern. Med. 2004;141:829–834. doi: 10.7326/0003-4819-141-11-200412070-00005. - DOI - PubMed
    1. Felker GM, et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine. 1999;78:270–283. doi: 10.1097/00005792-199907000-00005. - DOI - PubMed
    1. Leone O, et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc. Pathol. 2012;21:245–274. doi: 10.1016/j.carpath.2011.10.001. - DOI - PubMed

Publication types

MeSH terms